Speaker Profile
Ph.D., Chief Business Officer, Aima Diagnostics
Biography
Dr Lucas has over 10 years of experience in genomics, clinical solutions development and commercial leadership roles both at Illumina and Oxford Nanopore
Talk
Aima Diagnostics: new generation of liquid biopsy
Aíma Diagnostics created an AI-powered liquid biopsy platform basedon methylation and fragmentomics. It detects tumor signals, estimates tumor fraction, and identifies tissue of origin. Already evaluated on over 1,000 clinical samples, it enhances cancer monitoring, diagnostic support, and upcoming early detection capabilities with stage I and II data superior to leading competitors.
Clinical Dx Showcase:
Aima Diagnostics
Aima Diagnostics powerful multimodal biomarkers integrated with leading AI finds cancer signals earlier.
Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2027 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
